Key result
Aspirin at doses of 75-150 mg daily provides cardiovascular disease prevention benefits in secondary and high-risk primary prevention (>1% annual risk), but increases the risk of bleeding.
Why the study?
Does aspirin prevent cardiovascular events in patients with or at risk for cardiovascular disease?
Does aspirin prevent cardiovascular events in patients with or at risk for cardiovascular disease?
Low-dose aspirin is beneficial for secondary cardiovascular prevention and may be considered for primary prevention in high-risk individuals, provided the benefits outweigh the risks of bleeding.
Authors
No takes yet. Share an insight, caveat, or question.
Affirms individualized low-dose aspirin for secondary and high-risk primary prevention balancing bleeding risks; leaves open refined primary prevention thresholds.
Joseph Hung (2003) conducted a review in cardiovascular disease. Aspirin was evaluated. Aspirin at doses of 75-150 mg daily provides cardiovascular disease prevention benefits in secondary and high-risk primary prevention (>1% annual risk), but increases the risk of bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: